Targeted deep sequencing reveals APC mutations as predictors of overall survival in Chinese colorectal patients receiving adjuvant chemotherapy

References

• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132.
   PubMed Web of Science ®Google Scholar
• Ribic CM, Sargent DJ, Moore MJ, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med. 2003;349(3):247–257.
   PubMed Web of Science ®Google Scholar
• Kuebler JP, Wieand HS, O'Connell MJ, et al. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07. J Clin Oncol. 2007;25(16):2198–2204.
   PubMed Web of Science ®Google Scholar
• Andre T, Boni C, Navarro M, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol. 2009;27(19):3109–3116.
   PubMed Web of Science ®Google Scholar
• Schmoll HJ, Twelves C, Sun WJ, et al. Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials. Lancet Oncol. 2014;15(13):1481–1492.
   PubMed Web of Science ®Google Scholar
• Walther A, Johnstone E, Swanton C, et al. Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer. 2009;9(7):489–499.
   PubMed Web of Science ®Google Scholar
• Grady WM, Carethers JM. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology. 2008;135(4):1079–1099.
   PubMed Web of Science ®Google Scholar
• Sinicrope FA, Shi Q, Smyrk TC, et al. Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes. Gastroenterology. 2015;148(1):88–99.
   PubMed Web of Science ®Google Scholar
• Yoon HH, for the Alliance for Clinical Trials in Oncology, Tougeron D, Shi Q, et al. KRAS codon 12 and 13 mutations in relation to disease-free survival in BRAF-wild-type stage III Colon cancers from an adjuvant chemotherapy trial (N0147 alliance. ). Clin Cancer Res. 2014;20(11):3033–3043.
   PubMed Web of Science ®Google Scholar
• Groden J, Thliveris A, Samowitz W, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell. 1991;66(3):589–600.
   PubMed Web of Science ®Google Scholar
• Cottrell S, Bicknell D, Kaklamanis L, et al. Molecular analysis of APC mutations in familial adenomatous polyposis and sporadic colon carcinomas. Lancet. 1992;340(8820):626–630.
   PubMed Web of Science ®Google Scholar
• Polakis P. The adenomatous polyposis coli (APC) tumor suppressor. Biochim Biophys Acta. 1997;1332(3):F127–47.
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas N. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330–337.
   PubMed Web of Science ®Google Scholar
• Carethers JM, Jung BH. Genetics and genetic biomarkers in sporadic colorectal cancer. Gastroenterology. 2015;149(5):1177–1190 e3.
   PubMed Web of Science ®Google Scholar
• Zhang L, Shay JW. Multiple roles of APC and its therapeutic implications in colorectal cancer. J Natl Cancer Inst. 2017;109(8):djw332.
   Google Scholar
• Yu J, Wu WK, Li X, et al. Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer. Gut. 2015;64(4):636–645.
   PubMed Web of Science ®Google Scholar
• Giannakis M, Mu XJ, Shukla SA, et al. Genomic correlates of immune-cell infiltrates in colorectal carcinoma. Cell Rep. 2016;17(4):1206.
   Web of Science ®Google Scholar
• Lin SH, Raju GS, Huff C, et al. The somatic mutation landscape of premalignant colorectal adenoma. Gut. 2018;67(7):1299–1305.
   PubMed Web of Science ®Google Scholar
• Mardis E, McCombie WR. Library quantification: fluorometric quantitation of double-stranded or single-stranded DNA samples using the qubit system. Cold Spring Harb Protoc. 2017;2017(6):pdb prot094730.
   PubMedGoogle Scholar
• Panaro NJ, Yuen PK, Sakazume T, et al. Evaluation of DNA fragment sizing and quantification by the Agilent 2100 bioanalyzer. Clin Chem. 2000;46(11):1851–1853.
   PubMed Web of Science ®Google Scholar
• Diekstra A, Bosgoed E, Rikken A, et al. Translating sanger-based routine DNA diagnostics into generic massive parallel ion semiconductor sequencing. Clin Chem. 2015;61(1):154–162.
   PubMed Web of Science ®Google Scholar
• Shin S, Kim Y, Chul Oh S, et al. Validation and optimization of the ion torrent S5 XL sequencer and oncomine workflow for BRCA1 and BRCA2 genetic testing. Oncotarget. 2017;8(21):34858–34866.
   PubMedGoogle Scholar
• Gay LJ, Mitrou PN, Keen J, et al. Dietary, lifestyle and clinicopathological factors associated with APC mutations and promoter methylation in colorectal cancers from the EPIC-Norfolk study. J Pathol. 2012;228(3):405–415.
   PubMed Web of Science ®Google Scholar
• Yi M, Xu J, Liu P, et al. Comparative analysis of lifestyle factors, screening test use, and clinicopathologic features in association with survival among Asian Americans with colorectal cancer. Br J Cancer. 2013;108(7):1508–1514.
   PubMed Web of Science ®Google Scholar
• Wichmann MW, Muller C, Hornung HM, et al. Colorectal cancer study G. Gender differences in long-term survival of patients with colorectal cancer. Br J Surg. 2002;88(8):1092–1098.
   Web of Science ®Google Scholar
• McArdle CS, McMillan DC, Hole DJ. Male gender adversely affects survival following surgery for colorectal cancer. Br J Surg. 2003;90(6):711–715.
   PubMed Web of Science ®Google Scholar
• Hendifar A, Yang D, Lenz F, et al. Gender disparities in metastatic colorectal cancer survival. Clin Cancer Res. 2009;15(20):6391–6397.
   PubMed Web of Science ®Google Scholar
• Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003;3(5):330–338.
   PubMed Web of Science ®Google Scholar
• Zeineldin M, Neufeld KL. More than two decades of APC modeling in rodents. Biochim Biophys Acta. 2013;1836(1):80–89.
   PubMed Web of Science ®Google Scholar
• Chen S, Guttridge DC, You Z, Zhang Z, et al. Wnt-1 signaling inhibits apoptosis by activating beta-catenin/T cell factor-mediated transcription. J Cell Biol. 2001;152(1):87–96.
   PubMed Web of Science ®Google Scholar
• You L, He B, Uematsu K, et al. Inhibition of wnt-1 signaling induces apoptosis in beta-catenin-deficient mesothelioma cells. Cancer Res. 2004;64(10):3474–3478.
   PubMed Web of Science ®Google Scholar
• Lu D, Choi MY, Yu J, et al. Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells. Proc Natl Acad Sci U S A. 2011;108(32):13253–13257.
   PubMed Web of Science ®Google Scholar
• Ramachandran I, Thavathiru E, Ramalingam S, et al. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo. Oncogene. 2012;31(22):2725–2737.
   PubMed Web of Science ®Google Scholar
• Serebryannyy LA, Yemelyanov A, Gottardi CJ, et al. Nuclear alpha-catenin mediates the DNA damage response via beta-catenin and nuclear actin. J Cell Sci. 2017;130(10):1717–1729.
   PubMed Web of Science ®Google Scholar
• Narayan S, Jaiswal AS, Balusu R. Tumor suppressor APC blocks DNA polymerase beta-dependent strand displacement synthesis during long patch but not short patch base excision repair and increases sensitivity to methylmethane sulfonate. J Biol Chem. 2005;280(8):6942–6949.
   PubMed Web of Science ®Google Scholar
• Jaiswal AS, Narayan S. A novel function of adenomatous polyposis coli (APC) in regulating DNA repair. Cancer Lett. 2008;271(2):272–280.
   PubMed Web of Science ®Google Scholar
• Das D, Preet R, Mohapatra P, et al. 5-Fluorouracil mediated anti-cancer activity in Colon cancer cells is through the induction of adenomatous polyposis coli: Implication of the long-patch base excision repair pathway. DNA Repair. 2014;24:15–25.
   PubMed Web of Science ®Google Scholar
• Moseley JB, Bartolini F, Okada K, et al. Regulated binding of adenomatous polyposis coli protein to actin. J Biol Chem. 2007;282(17):12661–12668.
   PubMed Web of Science ®Google Scholar
• Okada K, Bartolini F, Deaconescu AM, et al. Adenomatous polyposis coli protein nucleates actin assembly and synergizes with the formin mDia1. J Cell Biol. 2010;189(7):1087–1096.
   PubMed Web of Science ®Google Scholar
• Nakamura M, Zhou XZ, Lu KP. Critical role for the EB1 and APC interaction in the regulation of microtubule polymerization. Curr Biol. 2001;11(13):1062–1067.
   PubMed Web of Science ®Google Scholar
• Slep KC, Rogers SL, Elliott SL, et al. Structural determinants for EB1-mediated recruitment of APC and spectraplakins to the microtubule plus end. J Cell Biol. 2005;168(4):587–598.
   PubMed Web of Science ®Google Scholar
• Green RA, Kaplan KB. Chromosome instability in colorectal tumor cells is associated with defects in microtubule plus-end attachments caused by a dominant mutation in APC. J Cell Biol. 2003;163(5):949–961.
   PubMed Web of Science ®Google Scholar
• Tighe A, Johnson VL, Taylor SS. Truncating APC mutations have dominant effects on proliferation, spindle checkpoint control, survival and chromosome stability. J Cell Sci. 2004;117(Pt 26):6339–6353.
   PubMed Web of Science ®Google Scholar
• Mouradov D, Domingo E, Gibbs P, et al. Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutations. Am J Gastroenterol. 2013;108(11):1785–1793.
   PubMed Web of Science ®Google Scholar
• Young J, Simms LA, Tarish J, et al. A family with attenuated familial adenomatous polyposis due to a mutation in the alternatively spliced region of APC exon 9. Hum Mutat. 1998;11(6):450–455.
   PubMed Web of Science ®Google Scholar
• Fostira F, Yannoukakos D. A distinct mutation on the alternative splice site of APC exon 9 results in attenuated familial adenomatous polyposis phenotype. Fam Cancer. 2010;9(3):395–400.
   PubMed Web of Science ®Google Scholar
• Xing Y, Clements WK, Le Trong I, et al. Crystal structure of a beta-catenin/APC complex reveals a critical role for APC phosphorylation in APC function. Mol Cell. 2004;15(4):523–533.
   PubMed Web of Science ®Google Scholar
• Xing Y, Clements WK, Kimelman D, et al. Crystal structure of a beta-catenin/axin complex suggests a mechanism for the beta-catenin destruction complex. Genes Dev. 2003;17(22):2753–2764.
   PubMed Web of Science ®Google Scholar
• van den Broek E, Krijgsman O, Sie D, et al. Genomic profiling of stage II and III Colon cancers reveals APC mutations to be associated with survival in stage III Colon cancer patients. Oncotarget. 2016;7(45):73876–73887.
   PubMedGoogle Scholar
• Mondaca S, Walch H, Nandakumar S, et al. Specific mutations in APC, but not alterations in DNA damage response, associate with outcomes of patients with metastatic colorectal cancer. Gastroenterology. 2020;159(5):1975–1978 e4.
   PubMed Web of Science ®Google Scholar
• Hankey W, McIlhatton MA, Ebede K, et al. Mutational mechanisms that activate Wnt signaling and predict outcomes in colorectal cancer patients. Cancer Res. 2018;78(3):617–630.
   PubMed Web of Science ®Google Scholar
• Lin PC, Yeh YM, Chan RH, et al. Sequential and co-occurring DNA damage response genetic mutations impact survival in stage III colorectal cancer patients receiving adjuvant oxaliplatin-based chemotherapy. BMC Cancer. 2021;21(1):217.
   PubMed Web of Science ®Google Scholar
• Conlin A, Smith G, Carey FA, et al. The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma. Gut. 2005;54(9):1283–1286.
   PubMed Web of Science ®Google Scholar
• Schell M, Yang M, Teer J, et al. A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC. Nat Commun. 2016;7:11743.
   PubMed Web of Science ®Google Scholar
• Jorissen RN, Christie M, Mouradov D, et al. Wild-type APC predicts poor prognosis in microsatellite-stable proximal colon cancer. Br J Cancer. 2015;113(6):979–988.
   PubMed Web of Science ®Google Scholar
• Venderbosch S, Nagtegaal I, Maughan T, et al. Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies. Clin Cancer Res. 2014;20(20):5322–5330.
   PubMed Web of Science ®Google Scholar
• Merok MA, Ahlquist T, Royrvik EC, et al. Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian series. Ann Oncol. 2013;24(5):1274–1282.
   PubMed Web of Science ®Google Scholar
• Chen SP, Wu CC, Lin SZ, et al. Prognostic significance of interaction between somatic APC mutations and 5-fluorouracil adjuvant chemotherapy in Taiwanese colorectal cancer subjects. Am J Clin Oncol. 2009;32(2):122–126.
   PubMed Web of Science ®Google Scholar